<?xml version='1.0' encoding='utf-8'?>
<document id="27373739"><sentence text="Bioaccumulation and biotransformation of the beta-blocker propranolol in multigenerational exposure to Daphnia magna."><entity charOffset="58-69" id="DDI-PubMed.27373739.s1.e0" text="propranolol" /></sentence><sentence text="Multigenerational bioaccumulation and biotransformation activity and short-term kinetics (e" /><sentence text="g" /><sentence text=", uptake and depuration) of propranolol in Daphnia magna were investigated at environmental concentration"><entity charOffset="28-39" id="DDI-PubMed.27373739.s4.e0" text="propranolol" /></sentence><sentence text=" The body burden and the major metabolite, desisopropyl propranolol (DIP), of propranolol were quantified using LC-MS/MS at the end of each generation after exposure for 11 generations"><entity charOffset="43-67" id="DDI-PubMed.27373739.s5.e0" text="desisopropyl propranolol" /><entity charOffset="69-72" id="DDI-PubMed.27373739.s5.e1" text="DIP" /><entity charOffset="78-89" id="DDI-PubMed.27373739.s5.e2" text="propranolol" /><pair ddi="false" e1="DDI-PubMed.27373739.s5.e0" e2="DDI-PubMed.27373739.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27373739.s5.e0" e2="DDI-PubMed.27373739.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27373739.s5.e0" e2="DDI-PubMed.27373739.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27373739.s5.e1" e2="DDI-PubMed.27373739.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27373739.s5.e1" e2="DDI-PubMed.27373739.s5.e2" /></sentence><sentence text=" The accumulation of propranolol in D"><entity charOffset="21-32" id="DDI-PubMed.27373739.s6.e0" text="propranolol" /></sentence><sentence text=" magna at an environmental concentration of 0" /><sentence text="2 μg/L was not much different between the parent (F0) and the eleventh filial (F10) generation" /><sentence text=" However, at 28 μg/L, its accumulation was 1" /><sentence text="6 times higher-up to 18" /><sentence text="9 μg/g-in the F10 generation relative to the F0" /><sentence text=" In contrast to propranolol, DIP intensity gradually increased from F0 to F10 at 0"><entity charOffset="16-27" id="DDI-PubMed.27373739.s12.e0" text="propranolol" /><entity charOffset="29-39" id="DDI-PubMed.27373739.s12.e1" text="DIP" /><pair ddi="false" e1="DDI-PubMed.27373739.s12.e0" e2="DDI-PubMed.27373739.s12.e0" /><pair ddi="false" e1="DDI-PubMed.27373739.s12.e0" e2="DDI-PubMed.27373739.s12.e1" /></sentence><sentence text="2 μg/L, reflecting an increase in detoxification load and biotransformation performance; no increasing trend was observed at 28 μg/L" /><sentence text=" The bioaccumulation factor (BAF) showed higher values with a lower concentration and longer period of exposure" /><sentence text=" The average values of the BAF for 21 days of long-term exposure in successive 11 generations were 440" /><sentence text="4 ± 119" /><sentence text="7 and 1026" /><sentence text="5 ± 208" /><sentence text="6 L/kg for 28 μg/L and 0" /><sentence text="2 μg/L, respectively" /><sentence text=" These are comparable to the BAF of 192 for the short-term 72-h exposure at 28 μg/L in the parent generation" /><sentence text=" It is also recommended that future studies for pharmaceutical ingredients be conducted on drug-drug interaction and structural characteristics on the prediction of biotransformation activity and bioaccumulation rate" /><sentence text=" " /></document>